Author

Sudhesh Kumar

Observed name: Kumar, Sudhesh

Institution: Mayo Clinic

Observed institutions: Aga Khan University, Mayo Clinic

ORCID: 0000-0002-2046-4270

Observed ORCID: 0000-0002-2046-4270

OpenAlex ID: A5076087196

Is minimally invasive orthopedic surgery safer than open? A systematic review of systematic reviews

2022 · Wardah Rafaqat, Tashfeen Ahmad, et al. · International Journal of Surgery · 22

The mid‐term and long‐term effects of tourniquet use in total knee arthroplasty: systematic review

2022 · Wardah Rafaqat, Sudhesh Kumar, et al. · Journal of Experimental Orthopaedics · 8

Impact of Drain Placement on Postoperative Complications after Thyroidectomy for Substernal Goiter

2024 · Usama Waqar, Ayesha Nasir Hameed, et al. · International Archives of Otorhinolaryngology · 2

TP53 Mutations and Circulating Blasts ≥ 20% Are the Primary Determinants of Survival in Accelerated/Blast‐Phase Myeloproliferative Neoplasms Treated With Frontline Venetoclax Plus Hypomethylating Agent

2026 · Naseema Gangat, Momna Warraich, et al. · American Journal of Hematology · 1

Venetoclax Plus Hypomethylating Agent for 7‐ Versus 14‐ Versus 21‐ Versus 28‐Day Cycles in Newly‐Diagnosed Acute Myeloid Leukemia: ELN and Mayo Genetic Risk–Stratified Analysis in 540 Patients

2026 · Sudhesh Kumar, Momna Warraich, et al. · American Journal of Hematology

Older Age, STAG2 , and DNMT3A Mutations Predict Superior Posttransplant Survival in Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents

2026 · Momna Warraich, Sudhesh Kumar, et al. · American Journal of Hematology

Works count: 8

Citation count: 33

H-index: 2

I10-index: 1